Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

Like many pharma stocks, Eli Lilly (NYSE ... All of this has helped Lilly's revenue climb in the double digits in recent quarters and the stock price to take off. The shares have advanced more ...

On Monday, Barclays expressed a positive stance on Eli Lilly (NYSE:LLY) stock, maintaining an Overweight rating and a price target ...

Eli Lilly has recently unveiled significant advancements across its product line, including promising results from the BRAVE-AA-PEDS study on adolescents with severe alopecia areata and the ...

Eli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand anti-obesity drug Zepbound ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Like many pharma stocks, Eli Lilly (NYSE ... Learn More » All of this has helped Lilly's revenue climb in the double digits in recent quarters and the stock price to take off.

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...